===== phenotype 15=================================================================
proportion of pts: 0.217770725902
lambda: 12168.9041601
----------------------------------------
Diabetes	0.228
Hypertensive disease	0.194
Disorders of lipoid metabolism	0.176
Range name na	0.142
Disorders of the eye and adnexa	0.141
Arthropathies and related disorders	0.119
----------------------------------------
Antipyretics	0.157
Hypoglycemic Agents	0.155
Anti-Inflammatory Agents, Non-Steroidal	0.153
Cyclooxygenase Inhibitors	0.151
Antihypertensive Agents	0.141
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.124
Anticholesteremic Agents	0.119
===== phenotype 40=================================================================
proportion of pts: 0.197937326458
lambda: 11193.0548732
----------------------------------------
Disorders of lipoid metabolism	0.224
Hypertensive disease	0.218
Ischemic heart disease	0.211
Symptoms involving respiratory system and other chest symptoms	0.181
Range name na	0.166
----------------------------------------
Fibrinolytic Agents	0.164
Platelet Aggregation Inhibitors	0.157
Antipyretics	0.152
Cyclooxygenase Inhibitors	0.147
Anti-Inflammatory Agents, Non-Steroidal	0.147
Vasodilator Agents	0.119
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.114
===== phenotype 39=================================================================
proportion of pts: 0.212217374058
lambda: 10634.2288043
----------------------------------------
Arthropathies and related disorders	0.206
Hypertensive disease	0.206
Rheumatism, excluding the back	0.164
Disorders of lipoid metabolism	0.152
Dorsopathies	0.140
Symptoms involving respiratory system and other chest symptoms	0.131
----------------------------------------
Anti-Inflammatory Agents, Non-Steroidal	0.159
Antihypertensive Agents	0.157
Cyclooxygenase Inhibitors	0.153
Diuretics	0.143
Vasodilator Agents	0.137
Anti-Arrhythmia Agents	0.126
Calcium Channel Blockers	0.125
===== phenotype 33=================================================================
proportion of pts: 0.164220547402
lambda: 8818.36646249
----------------------------------------
Range name na	0.187
General symptoms	0.186
Disorders of lipoid metabolism	0.168
Rheumatism, excluding the back	0.165
Dorsopathies	0.157
Anemias	0.137
----------------------------------------
Fibrinolytic Agents	0.160
Platelet Aggregation Inhibitors	0.157
Antipyretics	0.150
Anti-Inflammatory Agents, Non-Steroidal	0.146
Cyclooxygenase Inhibitors	0.137
Antihypertensive Agents	0.131
Vasodilator Agents	0.118
===== phenotype 2=================================================================
proportion of pts: 0.165807219357
lambda: 8178.84379924
----------------------------------------
Range name na	0.194
Other forms of heart disease	0.186
Hypertensive disease	0.177
Disorders of lipoid metabolism	0.169
Ischemic heart disease	0.151
Arthropathies and related disorders	0.122
----------------------------------------
Anti-Arrhythmia Agents	0.179
Sympatholytics	0.166
Adrenergic beta-1 Receptor Antagonists	0.156
Anticholesteremic Agents	0.138
Rodenticides	0.129
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.117
Anticoagulants	0.114
===== phenotype 12=================================================================
proportion of pts: 0.153510511702
lambda: 7469.9226757
----------------------------------------
Other forms of heart disease	0.214
Hypertensive disease	0.181
Ischemic heart disease	0.173
Nephritis, nephrotic syndrome, and nephrosis	0.154
Other diseases of respiratory system	0.146
Disorders of fluid, electrolyte, and acid-base balance	0.131
----------------------------------------
Antihypertensive Agents	0.154
Antipyretics	0.152
Fibrinolytic Agents	0.151
Platelet Aggregation Inhibitors	0.145
Anti-Inflammatory Agents, Non-Steroidal	0.143
Cyclooxygenase Inhibitors	0.141
Vasodilator Agents	0.114
===== phenotype 0=================================================================
proportion of pts: 0.159460531535
lambda: 7221.67031467
----------------------------------------
Rheumatism, excluding the back	0.164
Hypertensive disease	0.157
Arthropathies and related disorders	0.148
General symptoms	0.146
Symptoms involving respiratory system and other chest symptoms	0.145
Range name na	0.123
Dorsopathies	0.117
----------------------------------------
Anti-Inflammatory Agents	0.226
Dermatologic Agents	0.177
Immunosuppressive Agents	0.165
Enzyme Inhibitors	0.165
Antirheumatic Agents	0.152
Antimetabolites, Antineoplastic	0.114
===== phenotype 18=================================================================
proportion of pts: 0.164617215391
lambda: 6994.36967704
----------------------------------------
Hypertensive disease	0.187
Disorders of lipoid metabolism	0.164
Range name na	0.148
Dorsopathies	0.133
Arthropathies and related disorders	0.131
Rheumatism, excluding the back	0.122
Symptoms involving respiratory system and other chest symptoms	0.115
----------------------------------------
Analgesics	0.177
Muscle Relaxants, Central	0.173
Analgesics, Opioid	0.171
Narcotics	0.168
Antidepressive Agents, Tricyclic	0.162
Calcium Channel Blockers	0.149
===== phenotype 21=================================================================
proportion of pts: 0.180483934946
lambda: 6749.51349427
----------------------------------------
Hypertensive disease	0.195
Range name na	0.172
Disorders of lipoid metabolism	0.167
Arthropathies and related disorders	0.157
Rheumatism, excluding the back	0.156
General symptoms	0.153
----------------------------------------
Anti-Ulcer Agents	0.192
Hypnotics and Sedatives	0.184
Anti-Anxiety Agents	0.169
Proton Pump Inhibitors	0.156
Histamine H1 Antagonists	0.152
Analgesics, Non-Narcotic	0.147
===== phenotype 44=================================================================
proportion of pts: 0.167790559302
lambda: 6742.56558481
----------------------------------------
Range name na	0.175
Hypertensive disease	0.162
General symptoms	0.141
Rheumatism, excluding the back	0.135
Diabetes	0.133
Other forms of heart disease	0.130
Symptoms involving skin and other integumentary tissue	0.124
----------------------------------------
Diuretics	0.244
Anti-Arrhythmia Agents	0.203
Sodium Potassium Chloride Symporter Inhibitors	0.201
Sympatholytics	0.182
Adrenergic beta-1 Receptor Antagonists	0.171
===== phenotype 1=================================================================
proportion of pts: 0.130503768346
lambda: 6549.12832201
----------------------------------------
Hypertensive disease	0.281
Disorders of lipoid metabolism	0.258
Range name na	0.172
Diabetes	0.154
Arthropathies and related disorders	0.134
----------------------------------------
Folic Acid Antagonists	0.136
Nucleic Acid Synthesis Inhibitors	0.136
Abortifacient Agents, Nonsteroidal	0.135
Antimetabolites, Antineoplastic	0.125
Immunosuppressive Agents	0.121
Dermatologic Agents	0.118
Enzyme Inhibitors	0.116
Antirheumatic Agents	0.113
===== phenotype 4=================================================================
proportion of pts: 0.178897262991
lambda: 6123.64415374
----------------------------------------
Hypertensive disease	0.205
Disorders of lipoid metabolism	0.165
Other diseases of the upper respiratory tract	0.137
Range name na	0.131
Symptoms involving respiratory system and other chest symptoms	0.125
Diseases of esophagus, stomach, and duodenum	0.118
Acute respiratory infections	0.118
----------------------------------------
Bronchodilator Agents	0.270
Histamine H1 Antagonists, Non-Sedating	0.256
Anti-Allergic Agents	0.249
Dermatologic Agents	0.225
===== phenotype 14=================================================================
proportion of pts: 0.16858389528
lambda: 6094.91443227
----------------------------------------
Disorders of lipoid metabolism	0.174
Hypertensive disease	0.173
Diseases of esophagus, stomach, and duodenum	0.170
Disorders of the eye and adnexa	0.126
Diabetes	0.123
Rheumatism, excluding the back	0.119
Acute respiratory infections	0.114
----------------------------------------
Anti-Ulcer Agents	0.216
Proton Pump Inhibitors	0.199
Antihypertensive Agents	0.196
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.195
Anticholesteremic Agents	0.195
===== phenotype 35=================================================================
proportion of pts: 0.167790559302
lambda: 6066.73092809
----------------------------------------
Other symptoms involving abdomen and pelvis	0.173
Symptoms involving digestive system	0.156
Symptoms involving respiratory system and other chest symptoms	0.151
General symptoms	0.141
Diseases of esophagus, stomach, and duodenum	0.136
Hypertensive disease	0.127
Disorders of lipoid metabolism	0.116
----------------------------------------
Antihypertensive Agents	0.231
Platelet Aggregation Inhibitors	0.208
Anti-Ulcer Agents	0.203
Proton Pump Inhibitors	0.181
Anti-Arrhythmia Agents	0.177
===== phenotype 27=================================================================
proportion of pts: 0.133280444268
lambda: 5906.66099574
----------------------------------------
Range name na	0.185
Hypertensive disease	0.169
Other forms of heart disease	0.157
Symptoms involving respiratory system and other chest symptoms	0.141
Other diseases of respiratory system	0.119
Ischemic heart disease	0.118
Anemias	0.111
----------------------------------------
Antiemetics	0.161
Vitamins	0.160
Analgesics, Opioid	0.151
Anti-Anxiety Agents	0.147
Anesthetics, Local	0.137
Antipruritics	0.131
Cathartics	0.112
===== phenotype 25=================================================================
proportion of pts: 0.126933756446
lambda: 5728.16420087
----------------------------------------
Hypertensive disease	0.212
Range name na	0.183
Arthropathies and related disorders	0.175
Rheumatism, excluding the back	0.165
Dorsopathies	0.143
Diabetes	0.122
----------------------------------------
Anticonvulsants	0.223
Antiparkinson Agents	0.180
Excitatory Amino Acid Antagonists	0.178
Antimanic Agents	0.169
Calcium Channel Blockers	0.133
Anti-Bacterial Agents	0.116
===== phenotype 8=================================================================
proportion of pts: 0.156287187624
lambda: 5607.52641076
----------------------------------------
Range name na	0.190
Hypertensive disease	0.189
Symptoms involving respiratory system and other chest symptoms	0.182
Other forms of heart disease	0.170
General symptoms	0.152
Disorders of lipoid metabolism	0.117
----------------------------------------
Anti-Bacterial Agents	0.204
Analgesics, Non-Narcotic	0.191
Bone Density Conservation Agents	0.162
Topoisomerase II Inhibitors	0.156
Anti-Infective Agents, Urinary	0.151
Anticoagulants	0.137
===== phenotype 20=================================================================
proportion of pts: 0.184450614835
lambda: 5520.00224455
----------------------------------------
Hypertensive disease	0.217
General symptoms	0.185
Symptoms involving respiratory system and other chest symptoms	0.170
Diabetes	0.156
Other diseases of the upper respiratory tract	0.143
Acute respiratory infections	0.129
----------------------------------------
Antihypertensive Agents	0.199
Anti-Arrhythmia Agents	0.178
Anti-Allergic Agents	0.169
Vitamins	0.159
Antioxidants	0.156
Sympatholytics	0.140
===== phenotype 36=================================================================
proportion of pts: 0.145180483935
lambda: 4997.86466729
----------------------------------------
Hypertensive disease	0.203
Diabetes	0.201
Disorders of lipoid metabolism	0.168
Range name na	0.155
Dorsopathies	0.143
Other symptoms involving abdomen and pelvis	0.130
----------------------------------------
Antiemetics	0.169
Anti-Anxiety Agents	0.164
Antipruritics	0.159
Anti-Bacterial Agents	0.142
Hypoglycemic Agents	0.128
Bone Density Conservation Agents	0.124
Narcotics	0.113
===== phenotype 5=================================================================
proportion of pts: 0.154700515668
lambda: 4921.17615409
----------------------------------------
Hypertensive disease	0.181
Disorders of lipoid metabolism	0.162
Range name na	0.151
Other forms of heart disease	0.138
Arthropathies and related disorders	0.132
Other symptoms involving abdomen and pelvis	0.125
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.112
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.230
Vasodilator Agents	0.206
Anti-Allergic Agents	0.189
Anticholesteremic Agents	0.188
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.186
===== phenotype 3=================================================================
proportion of pts: 0.180880602935
lambda: 4915.44210751
----------------------------------------
Hypertensive disease	0.221
Disorders of lipoid metabolism	0.215
Symptoms involving respiratory system and other chest symptoms	0.164
Diabetes	0.146
Range name na	0.139
Acute respiratory infections	0.114
----------------------------------------
Hypnotics and Sedatives	0.226
Serotonin Uptake Inhibitors	0.208
Anti-Allergic Agents	0.192
Analgesics, Non-Narcotic	0.192
Antidepressive Agents, Second-Generation	0.182
===== phenotype 37=================================================================
proportion of pts: 0.176517255058
lambda: 4801.8322473
----------------------------------------
Other diseases of urinary system	0.245
Symptoms involving urinary system	0.230
Hypertensive disease	0.221
Disorders of lipoid metabolism	0.173
Other disorders of female genital tract	0.131
----------------------------------------
Antihypertensive Agents	0.215
Antipyretics	0.213
Anti-Inflammatory Agents, Non-Steroidal	0.210
Cyclooxygenase Inhibitors	0.204
Anti-Allergic Agents	0.158
===== phenotype 22=================================================================
proportion of pts: 0.131693772313
lambda: 4201.69786839
----------------------------------------
Dorsopathies	0.227
Na	0.215
General symptoms	0.191
Arthropathies and related disorders	0.189
Diseases of esophagus, stomach, and duodenum	0.179
----------------------------------------
Serotonin Uptake Inhibitors	0.190
Anti-Anxiety Agents	0.147
Analgesics, Non-Narcotic	0.146
Analgesics	0.139
Antidepressive Agents, Second-Generation	0.135
Hypnotics and Sedatives	0.129
Calcium Channel Blockers	0.114
===== phenotype 23=================================================================
proportion of pts: 0.152717175724
lambda: 4152.92601091
----------------------------------------
Symptoms involving respiratory system and other chest symptoms	0.226
Diabetes	0.184
Disorders of lipoid metabolism	0.162
Ischemic heart disease	0.162
Dorsopathies	0.142
Other diseases of urinary system	0.126
----------------------------------------
Hypolipidemic Agents	0.274
Anticholesteremic Agents	0.273
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.243
Hypoglycemic Agents	0.211
===== phenotype 6=================================================================
proportion of pts: 0.171757239191
lambda: 3924.49185328
----------------------------------------
Hypertensive disease	0.229
Disorders of lipoid metabolism	0.196
Arthropathies and related disorders	0.169
Rheumatism, excluding the back	0.156
Organic sleep disorders	0.127
Disorders of the eye and adnexa	0.122
----------------------------------------
Hypolipidemic Agents	0.365
Anticholesteremic Agents	0.320
Hydroxymethylglutaryl-CoA Reductase Inhibitors	0.315
===== phenotype 38=================================================================
proportion of pts: 0.149543831813
lambda: 3698.09894565
----------------------------------------
Hypertensive disease	0.244
Disorders of lipoid metabolism	0.236
Symptoms involving respiratory system and other chest symptoms	0.219
Other forms of heart disease	0.165
Chronic obstructive pulmonary disease and allied conditions	0.135
----------------------------------------
Diuretics	0.258
Glucocorticoids	0.236
Sodium Potassium Chloride Symporter Inhibitors	0.198
Enzyme Inhibitors	0.164
Gout Suppressants	0.144
===== phenotype 28=================================================================
proportion of pts: 0.157477191591
lambda: 3657.82557583
----------------------------------------
Hypertensive disease	0.236
Symptoms involving respiratory system and other chest symptoms	0.188
Disorders of lipoid metabolism	0.182
Ischemic heart disease	0.138
Other diseases of skin and subcutaneous tissue	0.131
Chronic obstructive pulmonary disease and allied conditions	0.125
----------------------------------------
Angiotensin-Converting Enzyme Inhibitors	0.259
Anti-Bacterial Agents	0.233
Anti-Ulcer Agents	0.197
Antifungal Agents	0.157
Antimalarials	0.154
===== phenotype 17=================================================================
proportion of pts: 0.139230464102
lambda: 3575.10347364
----------------------------------------
Hypertensive disease	0.214
Symptoms involving respiratory system and other chest symptoms	0.180
Disorders of lipoid metabolism	0.164
Chronic obstructive pulmonary disease and allied conditions	0.157
Range name na	0.155
General symptoms	0.130
----------------------------------------
Bronchodilator Agents	0.348
Tocolytic Agents	0.344
Adrenergic beta-2 Receptor Agonists	0.308
===== phenotype 30=================================================================
proportion of pts: 0.148353827846
lambda: 3372.00789797
----------------------------------------
Hypertensive disease	0.219
Range name na	0.186
General symptoms	0.179
Symptoms involving respiratory system and other chest symptoms	0.153
Other diseases of urinary system	0.141
Other diseases of intestines and peritoneum	0.122
----------------------------------------
Serotonin Uptake Inhibitors	0.234
Anti-Anxiety Agents	0.229
Antidepressive Agents, Second-Generation	0.207
Antipsychotic Agents	0.184
Anti-Infective Agents	0.146
===== phenotype 31=================================================================
proportion of pts: 0.148750495835
lambda: 3300.57572824
----------------------------------------
Other forms of heart disease	0.230
Range name na	0.226
Symptoms involving respiratory system and other chest symptoms	0.205
Hypertensive disease	0.179
Other diseases of respiratory system	0.160
----------------------------------------
Anti-Ulcer Agents	0.282
Calcium Channel Blockers	0.263
Vasodilator Agents	0.236
Proton Pump Inhibitors	0.219
===== phenotype 7=================================================================
proportion of pts: 0.145180483935
lambda: 3206.41682564
----------------------------------------
Hypertensive disease	0.274
Rheumatism, excluding the back	0.225
Range name na	0.199
Symptoms involving respiratory system and other chest symptoms	0.164
Other symptoms involving abdomen and pelvis	0.138
----------------------------------------
Serotonin Uptake Inhibitors	0.273
Antidepressive Agents, Second-Generation	0.199
Analgesics	0.189
Antidepressive Agents	0.176
Dopamine Uptake Inhibitors	0.163
===== phenotype 47=================================================================
proportion of pts: 0.155097183657
lambda: 2974.36397533
----------------------------------------
Disorders of lipoid metabolism	0.247
Symptoms involving respiratory system and other chest symptoms	0.237
Hypertensive disease	0.224
Other diseases of skin and subcutaneous tissue	0.163
Organic sleep disorders	0.129
----------------------------------------
Adrenergic beta-1 Receptor Antagonists	0.350
Sympatholytics	0.345
Anti-Arrhythmia Agents	0.305
===== phenotype 13=================================================================
proportion of pts: 0.149147163824
lambda: 2822.21432103
----------------------------------------
General symptoms	0.196
Dorsopathies	0.159
Symptoms involving skin and other integumentary tissue	0.154
Na	0.126
Symptoms involving head and neck	0.124
Neurotic, personality, nonpsychotic disorders	0.123
Cerebrovascular disease	0.119
----------------------------------------
Antipyretics	0.368
Cyclooxygenase Inhibitors	0.340
Anti-Allergic Agents	0.292
===== phenotype 32=================================================================
proportion of pts: 0.150733835779
lambda: 2462.32209299
----------------------------------------
Hypertensive disease	0.233
Disorders of lipoid metabolism	0.218
Range name na	0.155
Nutritional deficiencies	0.153
General symptoms	0.128
Diabetes	0.113
----------------------------------------
Vitamins	0.533
Bone Density Conservation Agents	0.467
===== phenotype 24=================================================================
proportion of pts: 0.156683855613
lambda: 2121.90051297
----------------------------------------
Hypertensive disease	0.182
Range name na	0.161
Dorsopathies	0.142
Symptoms involving respiratory system and other chest symptoms	0.137
Arthropathies and related disorders	0.135
Rheumatism, excluding the back	0.125
Disorders of lipoid metabolism	0.118
----------------------------------------
Proton Pump Inhibitors	0.526
Adjuvants, Anesthesia	0.474
===== phenotype 9=================================================================
proportion of pts: 0.174930583102
lambda: 2107.05794454
----------------------------------------
Range name na	0.249
Disorders of the eye and adnexa	0.229
Other diseases of skin and subcutaneous tissue	0.145
Ischemic heart disease	0.131
Other inflammatory conditions of skin and subcutaneous tissue	0.124
Nutritional deficiencies	0.121
----------------------------------------
Antihypertensive Agents	0.514
Anti-Inflammatory Agents	0.486
===== phenotype 10=================================================================
proportion of pts: 0.130503768346
lambda: 2104.99976664
----------------------------------------
Range name na	0.185
Disorders of the eye and adnexa	0.174
Hypertensive disease	0.171
Other forms of heart disease	0.171
Disorders of lipoid metabolism	0.160
Other diseases of skin and subcutaneous tissue	0.139
----------------------------------------
Enzyme Inhibitors	0.381
Immunosuppressive Agents	0.344
Antirheumatic Agents	0.275
===== phenotype 46=================================================================
proportion of pts: 0.130900436335
lambda: 1834.78946089
----------------------------------------
Disorders of lipoid metabolism	0.191
Hypertensive disease	0.190
Arthropathies and related disorders	0.167
Ischemic heart disease	0.162
Diseases of esophagus, stomach, and duodenum	0.147
Diabetes	0.144
----------------------------------------
Anti-Ulcer Agents	0.507
Proton Pump Inhibitors	0.493
===== phenotype 34=================================================================
proportion of pts: 0.148353827846
lambda: 1714.6896648
----------------------------------------
Other diseases of skin and subcutaneous tissue	0.228
Hypertensive disease	0.199
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.169
Anemias	0.143
Other inflammatory conditions of skin and subcutaneous tissue	0.131
Diseases of arteries, arterioles, and capillaries	0.129
----------------------------------------
Antipyretics	0.506
Antihypertensive Agents	0.494
===== phenotype 26=================================================================
proportion of pts: 0.170170567235
lambda: 1438.69770792
----------------------------------------
Hypertensive disease	0.162
Disorders of lipoid metabolism	0.152
Range name na	0.145
Other diseases of the upper respiratory tract	0.143
Symptoms involving respiratory system and other chest symptoms	0.136
Acute respiratory infections	0.133
Arthropathies and related disorders	0.130
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 43=================================================================
proportion of pts: 0.161840539468
lambda: 1136.83928352
----------------------------------------
Symptoms involving skin and other integumentary tissue	0.193
Rheumatism, excluding the back	0.182
Arthropathies and related disorders	0.181
Disorders of the peripheral nervous system	0.154
Infections of skin and subcutaneous tissue	0.148
Osteopathies, chondropathies, and acquired musculoskeletal deformities	0.143
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 49=================================================================
proportion of pts: 0.130900436335
lambda: 908.921347533
----------------------------------------
Range name na	0.210
Other forms of heart disease	0.188
Disorders of thyroid gland	0.169
Symptoms involving respiratory system and other chest symptoms	0.157
Diseases of veins and lymphatics, and other diseases of circulatory system	0.141
Hypertensive disease	0.135
----------------------------------------
Antihypertensive Agents	1.000
===== phenotype 11=================================================================
proportion of pts: 0.12177707259
lambda: 825.495135065
----------------------------------------
General symptoms	0.224
Symptoms involving skin and other integumentary tissue	0.194
Diabetes	0.158
Disorders of thyroid gland	0.153
Organic sleep disorders	0.139
Symptoms involving digestive system	0.132
----------------------------------------
Calcium Channel Blockers	1.000
===== phenotype 16=================================================================
proportion of pts: 0.117810392701
lambda: 799.186662738
----------------------------------------
Hypertensive disease	0.242
Range name na	0.207
Arthropathies and related disorders	0.204
Rheumatism, excluding the back	0.188
Disorders of thyroid gland	0.159
----------------------------------------
Analgesics, Non-Narcotic	1.000
===== phenotype 42=================================================================
proportion of pts: 0.11820706069
lambda: 669.005965294
----------------------------------------
Anemias	0.283
Nephritis, nephrotic syndrome, and nephrosis	0.208
Disorders of fluid, electrolyte, and acid-base balance	0.182
Diabetes	0.175
Nutritional deficiencies	0.152
----------------------------------------
Anti-Ulcer Agents	1.000
===== phenotype 29=================================================================
proportion of pts: 0.125743752479
lambda: 668.735592336
----------------------------------------
Symptoms involving digestive system	0.244
Anemias	0.182
Organic sleep disorders	0.172
Other diseases of intestines and peritoneum	0.141
Na	0.133
Overweight, obesity and other hyperalimentation	0.129
----------------------------------------
Anti-Allergic Agents	1.000
===== phenotype 48=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 45=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 41=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
===== phenotype 19=================================================================
proportion of pts: 0.0
lambda: 1.0
----------------------------------------
----------------------------------------
